A synergistic polyphosphoester-based co-delivery system of the anticancer drug doxorubicin and the tumor suppressor gene p53 for lung cancer therapy-Reference-Cited by-同舟云学术

A synergistic polyphosphoester-based co-delivery system of the anticancer drug doxorubicin and the tumor suppressor gene p53 for lung cancer therapy

Author:

Liu Jie¹²³⁴⁵,He Jinlin¹²³⁴⁵^ORCID,Zhang Mingzu¹²³⁴⁵,Xu Guoqiang⁶⁷⁸⁹,Ni Peihong¹²³⁴⁵^ORCID

Affiliation:

1. College of Chemistry

2. Chemical Engineering and Materials Science

3. State and Local Joint Engineering Laboratory for Novel Functional Polymeric Materials

4. Jiangsu Key Laboratory of Advanced Functional Polymer Design and Application

5. Suzhou Key Laboratory of Macromolecular Design and Precision Synthesis

6. Jiangsu Key Laboratory of Neuropsychiatric Diseases and College of Pharmaceutical Sciences

7. Soochow University

8. Suzhou

9. P. R. China

Abstract

Hybrid micelles composed of polymeric prodrug and gene carrier were constructed by polyphosphoester-based co-delivery system for lung cancer therapy.

Funder

Natural Science Foundation of Jiangsu Province

National Natural Science Foundation of China

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering,General Chemistry,General Medicine

Link

Reference59 articles.

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

5. Inhalable Prodrugs for Pulmonary Therapeutics;Pulmonary Drug Delivery Systems: Material and Technological Advances;2023